IMM 7.02% 30.5¢ immutep limited

Keytruda Is effectIve on Its own In approxImatley 40% of...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 863 Posts.
    lightbulb Created with Sketch. 24
    Keytruda Is effectIve on Its own In approxImatley 40% of melanoma cases treated if memory serves me. There is no mention of the fail in the latest report.
    The tactimel trial PartA is designed to treat patients who have had a suboptimal response to keytruda on its own. These 18 patients in the trial PartA have been given efti as well as keytruda in escalating doses.
    Part B has a cohort of 6 patients with melanoma who have been given keytruda + efti30mg from the very beginning of their treatment.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
30.5¢
Change
0.020(7.02%)
Mkt cap ! $486.6M
Open High Low Value Volume
29.0¢ 31.0¢ 29.0¢ $1.171M 3.900M

Buyers (Bids)

No. Vol. Price($)
5 101067 30.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 8068 2
View Market Depth
Last trade - 16.10pm 22/11/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.